Internal dynamics control activation and activity of the autoinhibited Vav DH domain

Nature Structural and Molecular Biology

Volumn 15, Issue 6, 2008, Pages 613-618

  Li, Pilong ^a   Martins, Ilídio R S ^a,b   Amarasinghe, Gaya K ^a,c   Rosen, Michael K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VAV PROTEIN;

ARTICLE; CATALYSIS; DBL HOMOLOGY DOMAIN; MOLECULAR DYNAMICS; MUTANT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; CLONING, MOLECULAR; FEEDBACK; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MOTION; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-VAV;

EID: 44849141472     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.1428     Document Type: Article

References (29)

1. Kay, L.E. NMR studies of protein structure and dynamics. J. Magn. Reson. 173, 193-207 (2005).
2. Kern, D. & Zuiderweg, E.R. The role of dynamics in allosteric regulation. Curr. Opin. Struct. Biol. 13, 748-757 (2003).
3. Palmer, A.G. III, Kroenke, C.D. & Loria, J.P. Nuclear magnetic resonance methods for quantifying microsecond-to-millisecond motions in biological macromolecules. Methods Enzymol. 339, 204-238 (2001).
4. Dueber, J.E., Yeh, B.J., Chak, K. & Lim, W.A. Reprogramming control of an allosteric signaling switch through modular recombination. Science 301, 1904-1908 (2003).
5. Pufall, M.A. & Graves, B.J. Autoinhibitory domains: modular effectors of cellular regulation. Annu. Rev. Cell Dev. Biol. 18, 421-462 (2002).
6. Bustelo, X.R. Vav proteins, adaptors and cell signaling. Oncogene 20, 6372-6381 (2001).
7. Turner, M. & Billadeau, D.D. VAV proteins as signal integrators for multi-subunit immune-recognition receptors. Nat. Rev. Immunol. 2, 476-486 (2002).
8. Tybulewicz, V.L. Vav-family proteins in T-cell signalling. Curr. Opin. Immunol. 17, 267-274 (2005).
9. Abe, K., Whitehead, I.P., O'Bryan, J.P. & Der, C.J. Involvement of NH(2)-terminal sequences in the negative regulation of Vav signaling and transforming activity. J. Biol. Chem. 274, 30410-30418 (1999).
10. Heo, J., Thapar, R. & Campbell, S.L. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors. Biochemistry 44, 6573-6585 (2005).
11. Aghazadeh, B., Lowry, W.E., Huang, X.Y. & Rosen, M.K. Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation. Cell 102, 625-633 (2000).
12. Lopez-Lago, M., Lee, H., Cruz, C., Movilla, N. & Bustelo, X.R. Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav. Mol. Cell. Biol. 20, 1678-1691 (2000).
13. Movilla, N. & Bustelo, X.R. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol. Cell. Biol. 19, 7870-7885 (1999).
14. Amarasinghe, G.K. & Rosen, M.K. Acidic region tyrosines provide access points for allosteric activation of the autoinhibited Vav1 dbl homology domain. Biochemistry 44, 15257-15268 (2005).
15. Lundstrom, P., Vallurupalli, P., Religa, T.L., Dahlquist, F.W. & Kay, L.E. A single-quantum methyl 13C-relaxation dispersion experiment with improved sensitivity. J. Biomol. NMR 38, 79-88 (2007).
16. Korzhnev, D.M. et al. Low-populated folding intermediates of Fyn SH3 characterized by relaxation dispersion NMR. Nature 430, 586-590 (2004).
17. Korzhnev, D.M., Neudecker, P., Mittermaier, A., Orekhov, V.Y. & Kay, L.E. Multiple-site exchange in proteins studied with a suite of six NMR relaxation dispersion experiments: an application to the folding of a Fyn SH3 domain mutant. J. Am. Chem. Soc. 127, 15602-15611 (2005).
18. Volkman, B.F., Lipson, D., Wemmer, D.E. & Kern, D. Two-state allosteric behavior in a single-domain signaling protein. Science 291, 2429-2433 (2001).
19. Selzer, T., Albeck, S. & Schreiber, G. Rational design of faster associating and tighter binding protein complexes. Nat. Struct. Biol. 7, 537-541 (2000).
20. Llorca, O., Arias-Palomo, E., Zugaza, J.L. & Bustelo, X.R. Global conformational rearrangements during the activation of the GDP/GTP exchange factor Vav3. EMBO J. 24, 1330-1340 (2005).
21. Katzav, S., Martin-Zanca, D. & Barbacid, M. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8, 2283-2290 (1989).
22. Katzav, S., Cleveland, J.L., Heslop, H.E. & Pulido, D. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol. Cell. Biol. 11, 1912-1920 (1991).
23. Zugaza, J.L. et al. Structural determinants for the biological activity of Vav proteins. J. Biol. Chem. 277, 45377-45392 (2002).
24. Lim, W.A. The modular logic of signaling proteins: building allosteric switches from simple binding domains. Curr. Opin. Struct. Biol. 12, 61-68 (2002).
25. Pawson, T. Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116, 191-203 (2004).
26. Korzhnev, D.M., Kloiber, K., Kanelis, V., Tugarinov, V. & Kay, L.E. Probing slow dynamics in high molecular weight proteins by methyl-TROSY NMR spectroscopy: application to a 723-residue enzyme. J. Am. Chem. Soc. 126, 3964-3973 (2004).
27. Tollinger, M., Skrynnikov, N.R., Mulder, F.A., Forman-Kay, J.D. & Kay, L.E. Slow dynamics in folded and unfolded states of an SH3 domain. J. Am. Chem. Soc. 123, 11341-11352 (2001).
28. Mulder, F.A., Hon, B., Mittermaier, A., Dahlquist, F.W. & Kay, L.E. Slow internal dynamics in proteins: application of NMR relaxation dispersion spectroscopy to methyl groups in a cavity mutant of T4 lysozyme. J. Am. Chem. Soc. 124, 1443-1451 (2002).
29. Heckert, N.A. & Filliben, J.J. NIST Handbook 148: DATAPLOT Reference Manual. National Institute of Standards and Technology Handbook Series 〈http://www.itl.nist.gov/div898/software/dataplot.html/##〉 (2003).